News Sentiment

RIGL sentiment intelligence

Rigel Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 32.91 Week of 19 Jun 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+0.2% over one week, +13.4% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL)

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 0.2% Price digesting
Trend fit Trend inactive 13.4% over four weeks
Fair value 59.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 39
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
simplywall.st 11
Market source 11
PR Newswire 4
Seeking Alpha 3
Stock Traders Daily 3
TradingKey 2
Benzinga 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 18
Deals and strategy 5
Guidance 5
Analyst action 3
Balance sheet 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
Stock Titan Direct company coverage

Rigel (RIGL) investors back equity plan, ESPP and auditor at 2026 meeting

Rigel Pharmaceuticals stockholders approved amendments to the 2018 Equity Incentive Plan and the 2000 Employee Stock Purchase Plan, adding 500,000 and 360,000 shares respectively for future grants and purchases. All three director nominees were elected to serve until the 2029 ann

Tone
Positive 64/100
Event
Market update
Published
20 May 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Rigel (NASDAQ: RIGL) director awarded 5,750 RSUs vesting before annual meeting

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) director Michael Patrick Miller was granted 5,750 Restricted Stock Units (RSUs) as compensation, which will vest fully before the company's next Annual Meeting, provided he continues his service on the Board. This transaction, detailed in

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 12:10
Source
Stock Titan